Armata Pharmaceuticals, Inc. (ARMP) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 789K | 0 | 0 | 2.17M | 491K | 1.24M | 2.97M | 0 | 966K | 1.53M | 1.23M | 980K | 796K | 1.05M | 1.34M | 1.88M | 1.24M | 989K | 1.25M | 1.17M |
| Revenue Growth % | 60.69% | -100% | -100% | - | -49.17% | -19.18% | 142.69% | -100% | 21.36% | 45.39% | -8.45% | -47.96% | -35.6% | 6.27% | 6.95% | 61.22% | 15.95% | 96.23% | 334.38% | 3667.74% |
| Cost of Goods Sold | 457K | 0 | 0 | 366K | 377K | 380K | 313K | 315K | 317K | 293K | 221K | 200K | 9.6M | 9.57M | 8.4M | 9.02M | 8.03M | 4.81M | 5.63M | 5.22M |
| COGS % of Revenue | 57.92% | - | - | 16.87% | 76.78% | 30.77% | 10.53% | - | 32.82% | 19.18% | 18.04% | 20.41% | 1206.53% | 910.47% | 627.8% | 479.02% | 649.51% | 486.75% | 449.72% | 447.35% |
| Gross Profit | 332K | 0 | 0 | 1.8M | 114K | 855K | 2.66M | -315K | 649K | 1.24M | 1M | 780K | -8.81M | -8.52M | -7.06M | -7.14M | -6.79M | -3.83M | -4.38M | -4.06M |
| Gross Margin % | 42.08% | - | - | 83.13% | 23.22% | 69.23% | 89.47% | - | 67.18% | 80.82% | 81.96% | 79.59% | -1106.53% | -810.47% | -527.8% | -379.02% | -549.51% | -386.75% | -349.72% | -347.35% |
| Gross Profit Growth % | 191.23% | -100% | -100% | 672.38% | -82.43% | -30.77% | 164.94% | -140.38% | 107.37% | 114.5% | 114.22% | 110.93% | -29.68% | -122.69% | -61.42% | -75.92% | -106.82% | 14.54% | -15.8% | -55.02% |
| Operating Expenses | 9.12M | 13.82M | 7.78M | 8.65M | 8.3M | 11.39M | 12.41M | 11.6M | 10.88M | 10.81M | 11.34M | 10.41M | 2.54M | 1.81M | 1.56M | 2.08M | 1.98M | 2.22M | 1.77M | 2.14M |
| OpEx % of Revenue | 1155.51% | - | - | 398.66% | 1691.45% | 922.59% | 417.29% | - | 1125.98% | 707.72% | 925.71% | 1062.14% | 318.84% | 172.22% | 116.67% | 110.62% | 160.44% | 224.77% | 141.33% | 183.13% |
| Selling, General & Admin | 3.46M | 3.43M | 3.11M | 2.62M | 3.25M | 3.32M | 3.24M | 3.44M | 3.18M | 3.18M | 3.36M | 2.15M | 2.54M | 1.81M | 1.56M | 2.08M | 1.98M | 2.22M | 1.77M | 2.14M |
| SG&A % of Revenue | 438.91% | - | - | 120.75% | 662.53% | 269.07% | 109.12% | - | 328.99% | 208.05% | 274.45% | 219.39% | 318.84% | 172.22% | 116.67% | 110.62% | 160.44% | 224.77% | 141.33% | 183.13% |
| Research & Development | 6.11M | 6.07M | 5.82M | 6.39M | 5.43M | 8.45M | 9.48M | 8.47M | 8.02M | 7.93M | 7.98M | 8.26M | 9.6M | 9.57M | 8.4M | 9.02M | 8.03M | 4.81M | 5.63M | 5.22M |
| R&D % of Revenue | 774.52% | - | - | 294.79% | 1105.7% | 684.21% | 319.04% | - | 829.81% | 518.85% | 651.27% | 842.76% | 1206.53% | 910.47% | 627.8% | 479.02% | 649.51% | 486.75% | 449.72% | 447.35% |
| Other Operating Expenses | -457K | 1000K | -1000K | -366K | -377K | -379K | -323K | -315K | -317K | -293K | 0 | 0 | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K |
| Operating Income | -8.79M | -13.82M | -7.78M | -6.84M | -8.19M | -10.54M | -9.76M | -11.91M | -10.23M | -9.58M | -10.34M | -9.63M | -11.35M | -10.33M | -8.62M | -9.22M | -8.78M | -6.05M | -6.14M | -6.2M |
| Operating Margin % | -1113.43% | - | - | -315.54% | -1668.23% | -853.36% | -328.15% | - | -1058.8% | -626.9% | -843.76% | -982.55% | -1425.38% | -982.68% | -644.47% | -489.64% | -709.95% | -611.53% | -491.05% | -530.48% |
| Operating Income Growth % | -7.25% | -31.16% | 20.3% | 42.55% | 19.92% | -10.02% | 5.61% | -23.73% | 9.85% | 7.25% | -19.87% | -4.44% | -29.3% | -70.77% | -40.37% | -48.81% | -61.45% | 6.28% | -9.25% | -34.99% |
| EBITDA | -8.33M | -13.4M | -7.41M | -6.48M | -7.81M | -10.16M | -9.44M | -11.6M | -9.91M | -9.29M | -10.12M | -9.43M | -11.12M | -10.08M | -8.4M | -9.03M | -8.55M | -5.77M | -5.83M | -5.9M |
| EBITDA Margin % | -1055.51% | - | - | -298.66% | -1591.45% | -822.59% | -317.63% | - | -1025.98% | -607.72% | -825.71% | -962.14% | -1396.48% | -959.37% | -627.58% | -479.29% | -691.67% | -583.52% | -465.95% | -505.05% |
| EBITDA Growth % | -6.58% | -31.95% | 21.57% | 44.15% | 21.16% | -9.4% | 6.64% | -23.01% | 10.84% | 7.9% | -20.46% | -4.48% | -30.03% | -74.72% | -44.06% | -52.99% | -65.87% | 6.6% | -8.79% | -36.87% |
| D&A (Non-Cash Add-back) | 457K | 418K | 370K | 366K | 377K | 380K | 313K | 315K | 317K | 293K | 221K | 200K | 230K | 245K | 226K | 195K | 226K | 277K | 314K | 297K |
| EBIT | -8.79M | -119.46M | -22.33M | -12.49M | -2.93M | 5.88M | -2.56M | 11.7M | -23.2M | -18.4M | -29.98M | -3.55M | -11.35M | -10.33M | -8.62M | -9.22M | -8.78M | -6.05M | -6.14M | -6.2M |
| Net Interest Income | -5.5M | -4.7M | -4.26M | -3.7M | -3.54M | -3.15M | -2.63M | -2.5M | -1.77M | -1.38M | -1.13M | 46K | 18K | 14K | 9K | 5K | 1K | 1K | -2K | 2K |
| Interest Income | 60K | 131K | 90K | 108K | 59K | 130K | 294K | 221K | 52K | 68K | 47K | 46K | 18K | 14K | 9K | 5K | 1K | 1K | 0 | 2K |
| Interest Expense | 5.56M | 4.83M | 4.35M | 3.81M | 3.6M | 3.28M | 2.92M | 2.72M | 1.82M | 1.45M | 1.18M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2K | 0 |
| Other Income/Expense | -106.56M | -110.47M | -18.9M | -9.45M | 1.66M | 13.14M | 4.28M | 20.9M | -14.79M | -10.27M | -20.82M | 6.08M | -3.14M | 14K | 9K | 5K | 1K | 1K | 724K | 2K |
| Pretax Income | -115.35M | -124.3M | -26.68M | -16.3M | -6.53M | 2.6M | -5.48M | 8.99M | -25.02M | -19.85M | -31.16M | -3.55M | -14.49M | -10.31M | -8.61M | -9.21M | -8.77M | -6.05M | -5.42M | -6.19M |
| Pretax Margin % | -14619.26% | - | - | -751.27% | -1330.14% | 210.53% | -184.36% | - | -2590.17% | -1298.89% | -2543.76% | -361.94% | -1820.35% | -981.35% | -643.8% | -489.38% | -709.87% | -611.43% | -433.17% | -530.31% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -115.35M | -124.3M | -26.68M | -16.3M | -6.53M | 2.6M | -5.48M | 8.99M | -25.02M | -19.85M | -31.16M | -3.55M | -14.49M | -10.31M | -8.61M | -9.21M | -8.77M | -6.05M | -5.42M | -6.19M |
| Net Margin % | -14619.26% | - | - | -751.27% | -1330.14% | 210.53% | -184.36% | - | -2590.17% | -1298.89% | -2543.76% | -361.94% | -1820.35% | -981.35% | -643.8% | -489.38% | -709.87% | -611.43% | -433.17% | -530.31% |
| Net Income Growth % | -1666.13% | -4880.69% | -386.68% | -281.34% | 73.9% | 113.1% | 82.41% | 353.34% | -72.68% | -92.43% | -261.75% | 61.51% | -65.15% | -70.56% | -58.96% | -48.77% | -59.67% | 8.71% | 6.07% | -31.51% |
| Net Income (Continuing) | -115.35M | -124.3M | -26.68M | -16.3M | -6.53M | 2.6M | -5.48M | 8.99M | -25.02M | -19.85M | -31.16M | -3.55M | -14.49M | -10.31M | -8.61M | -9.21M | -8.77M | -6.05M | -5.42M | -6.19M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -3.16 | -3.42 | -0.74 | -0.45 | -0.18 | 0.04 | -0.15 | -0.25 | -0.69 | -0.55 | -0.86 | -0.10 | -0.40 | -0.29 | -0.24 | -0.26 | -0.30 | -0.25 | -0.22 | -0.25 |
| EPS Growth % | -1655.56% | -7872.73% | -393.33% | -80% | 73.91% | 108% | 82.56% | -154.32% | -72.5% | -89.66% | -258.33% | 62.19% | -33.33% | -16% | -9.09% | -4% | -11.11% | 37.5% | 29.03% | 3.85% |
| EPS (Basic) | -3.16 | -3.42 | -0.74 | -0.45 | -0.18 | 0.07 | -0.15 | -0.40 | -0.69 | -0.55 | -0.86 | -0.10 | -0.40 | -0.29 | -0.24 | -0.26 | -0.30 | -0.25 | -0.22 | -0.25 |
| Diluted Shares Outstanding | 36.53M | 36.34M | 36.23M | 36.19M | 36.18M | 59.08M | 36.18M | 58.25M | 36.12M | 36.1M | 36.09M | 36.07M | 36.05M | 36.05M | 36.04M | 36M | 29M | 26.3M | 24.82M | 24.76M |
| Basic Shares Outstanding | 36.53M | 36.34M | 36.23M | 36.19M | 36.18M | 36.18M | 36.18M | 36.15M | 36.12M | 36.1M | 36.09M | 36.07M | 36.05M | 36.05M | 36.04M | 36M | 29M | 26.3M | 24.82M | 24.76M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |